IRCT20230111057113N1 IRCT 2023-02-23 Shahid Beheshti University of Medical Sciences Evaluation the efficacy of D-Chiro-Inositol in endometriosis Evaluation the efficacy of D-Chiro-Inositol in pain relif in endometriosis 2023-02-21 anticipated 60 Complete https://irct.ir/trial/68717 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients will be randomly given a sealed envelope containing medicine, Blinding description: Patients will be randomly divided into two equal groups.The patients are discussed about the research plan and the method, the goals and the results obtained and An attempt is made to obtain the consent of the patients to participate in the study.Written consent is obtained from patients who agree to participate and Then they will be divided into case and control groups.In a random and double-blind manner, the medicine packages will be distributed by the doctor between the two groups. 2-3 Endometriosis is characterized by the presence of endometrial and stromal tissue outside the uterine cavity. Intervention 1: Intervention group: two tablets containing 1200 mg of DCI and 120 mg of alpha-lactalbumin for the first month and 600 mg of DCI and 60 mg of alpha-lactalbumin for the next 5 months. Intervention 2: Control group: Control group: tablets containing 600 mg of maltodextrin daily for 6 months. Yes - There is a plan to make this available What will be shared: Only a part of the data, such as the information related to the main result or the like, can be shared. When: The access period starts 6 months after the results are published To whom: The data will be available only to researchers working in academic and scientific institutions Conditions: For scientific studies and therapeutic use Where to obtain: Samaneh Esmaeili،dresmaeili@gmail.com How to obtain: Within a month of receiving the email Comments: